P. Carpenter

发表

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.

Jeffrey A. Cohen, H. Atkins, K. Sullivan, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late effects of chronic graft-versus-host disease.

P. Carpenter, 2008, Best practice & research. Clinical haematology.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.

J. Radich, W. Leisenring, S. Meshinchi, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Utilization of Chimeric Antigen Receptor (CAR) T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B cell non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

M. Bar, F. Awan, D. Miklos, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

R. Storb, B. Sandmaier, B. Storer, 2005, Bone Marrow Transplantation.

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)

M. Bar, G. Mufti, S. Grupp, 2019, Bone Marrow Transplantation.

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.

M. Bar, G. Mufti, S. Grupp, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

J. Ritz, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

R. Storb, B. Storer, F. Appelbaum, 2011, Blood.

Health consensus criteria and for chronic graft-versus-host disease according to National Comparative analysis of risk factors for acute graft-versus-host disease

R. Storb, B. Storer, F. Appelbaum, 2011 .

Chronic Graft-versus-Host Disease - Clinical Manifestations and Therapy

M. Flowers, S. Pavletic, P. Carpenter, 2009 .

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease

R. Storb, M. Flowers, P. Carpenter, 2005, Bone Marrow Transplantation.

Duration of immunosuppressive treatment for chronic graft-versus-host disease.

R. Storb, B. Storer, F. Appelbaum, 2004, Blood.

Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy.

M. Perales, A. Nagler, M. Mohty, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic risk factors for sclerotic graft-versus-host disease.

L. Zhao, B. Storer, E. Warren, 2014, Blood.

Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

M. Bar, S. Ott, A. Nagler, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long‐term follow‐up of children

P. Carpenter, 2021 .

Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.

M. Bar, Stephanie J. Lee, Jean C. Yi, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late infectious complications in hematopoietic cell transplantation survivors: a population-based study.

W. Leisenring, M. Boeckh, B. Mueller, 2020, Blood advances.

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.

B. Storer, C. Chesnut, J. Sanders, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy.

S. Crawford, P. Veys, R. Champlin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Guideline Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma : Guidelines from the American Society for Blood and Marrow Transplantation

J. Vose, M. Perales, A. Evens, 2015 .

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

J. Vose, M. Perales, A. Evens, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.

J. Radich, M. Mauro, M. Flowers, 2017, Blood.

Late effects in high‐risk neuroblastoma survivors treated with high‐dose chemotherapy and stem cell rescue

E. Chow, Julie R. Park, Navin Pinto, 2018, Pediatric blood & cancer.

Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.

F. Appelbaum, T. Gooley, E. Bryant, 2005, Blood.

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.

J. Radich, F. Appelbaum, M. Flowers, 2007, Blood.

transplantation for severe aplastic anemia Late effects among pediatric patients followed for nearly 4 decades after

R. Storb, B. Storer, J. Sanders, 2013 .

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.

H. Deeg, R. Storb, B. Storer, 2011, Blood.

Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.

M. Perales, J. Wingard, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.

R. Storb, B. Storer, F. Appelbaum, 2009, Blood.

Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors.

T. Lehky, Stephanie J. Lee, M. Flowers, 2022, Transplantation and cellular therapy.

Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series

Namita Singh, D. Suskind, Dale Lee, 2022, JPGN Reports.

Confounding Factors Affecting the National Institutes of Health (NIH) Chronic Graft-Versus-Host Disease Organ-Specific Score and Global Severity

B. Sandmaier, B. Storer, Stephanie J. Lee, 2016, Bone Marrow Transplantation.

Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.

K. Sullivan, L. Crofford, M. Pasquini, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.

D. Miklos, B. Storer, Jingxin Qiu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2017, Blood.

Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease.

Ruikang K. Wang, Tueng T. Shen, B. Storer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

W. Wood, B. Kurland, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study

J. Lai, M. MacMillan, K. Baird, 2014, Supportive Care in Cancer.

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

B. Storer, K. van Besien, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison between short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

B. Storer, Stephanie J. Lee, D. Couriel, 2011 .

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

M. Bar, G. Mufti, S. Grupp, 2021 .

Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant

K. Krull, Stephanie J. Lee, K. Syrjala, 2022, Blood advances.

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease

J. Kurtzberg, K. Mahadeo, E. Nemecek, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-Fc Receptor-Binding Humanized Anti-CD3 Antibodies Induce Apoptosis of Activated Human T Cells1

T. Gooley, C. Anasetti, J. Tso, 2000, The Journal of Immunology.

Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression

Stephanie J. Lee, M. Flowers, E. Krakow, 2022, Transplantation and Cellular Therapy.

American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplant Patients.

K. Syrjala, S. Hashmi, C. De Biase, 2022, Transplantation and cellular therapy.

Generic immunosuppressants in hematopoietic cell transplantation.

Ya-Chen Tina Shih, A. Kesselheim, F. Appelbaum, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

J. Fay, B. Storer, J. Wingard, 2009, Blood.

Steroid‐refractory graft‐vs.‐host disease: past, present and future

J. Sanders, P. Carpenter, 2003, Pediatric transplantation.

Advances in transplantation tolerance

C. Anasetti, P. Carpenter, Xue-Zhong Yu, 2001, The Lancet.

Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myeloid Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.

M. Sulis, J. Chewning, S. Meshinchi, 2022, Transplantation and cellular therapy.

A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

Philip R. Gafken, C. Bollard, S. Farag, 2022, Blood advances.

American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients.

T. Hohl, M. Boeckh, D. Kontoyiannis, 2021, Transplantation and cellular therapy.

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

TRANSPLANTATION Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013 .

How I conduct a comprehensive chronic graft-versus-host disease assessment.

P. Carpenter, 2011, Blood.

assessment How I conduct a comprehensive chronic graft-versus-host disease

P. Carpenter, 2011 .

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

J. Wingard, K. Ballen, Y. Nieto, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

M. Sorror, M. MacMillan, T. Gooley, 2022, Blood advances.

Secondary treatment of acute graft-versus-host disease: a critical review.

M. Flowers, Paul J. Martin, P. Carpenter, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.

R. Storb, W. Leisenring, F. Appelbaum, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.

R. Storb, B. Storer, F. Appelbaum, 2009, Blood.

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.

R. Storb, B. Storer, F. Appelbaum, 2011, Blood.

A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.

R. Storb, B. Storer, F. Appelbaum, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease

R. Storb, B. Storer, M. Mielcarek, 2014, Haematologica.

Management of acute graft-versus-host disease in children.

M. MacMillan, P. Carpenter, 2010, Pediatric clinics of North America.

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

B. Storer, F. Appelbaum, E. Warren, 2009, Blood.

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2014, Blood.

Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer

T. Loeffelholz, Z. Z. Quinn, S. Pergam, 2021, JAMA network open.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2018, Haematologica.

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.

M. Bar, B. Storer, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characteristics of chronic GVHD after cord blood transplantation

M. Flowers, T. Gooley, P. Martin, 2013, Bone Marrow Transplantation.

Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients

W. Leisenring, M. Boeckh, J. Englund, 2022, Bone Marrow Transplantation.

Ibrutinib treatment of pediatric chronic graft-versus-host disease: primary results from the phase 1/2 iMAGINE study.

G. Lucchini, K. Yoo, E. Nemecek, 2022, Transplantation and cellular therapy.

Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2016 .

A dose‐intensive, cyclophosphamide‐based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood

G. McCowage, I. Toogood, P. Shaw, 1997, Cancer.

Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources

Julie R. Park, K. Baker, P. Carpenter, 2018, Journal of global oncology.

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.

A. Paci, M. Perales, M. Mohty, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

S. Crawford, P. Veys, R. Champlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

chronic GVHD Evaluation of NIH consensus criteria for classification of late acute and

B. Storer, F. Appelbaum, E. Warren, 2009 .

prednisone does not compromise patient outcomes Initial therapy of acute graft-versus-host disease with low-dose

R. Storb, B. Storer, F. Appelbaum, 2009 .

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

B. Storer, F. Appelbaum, E. Warren, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study Group.

G. McCowage, P. Shaw, P. Carpenter, 1997, Medical and pediatric oncology.

Vitamin A to reduce gut leak and GVHD?

P. Carpenter, 2017, Blood.

Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.

H. Deeg, R. Storb, F. Appelbaum, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines.

M. Robin, G. Garcia-Manero, Z. DeFilipp, 2022, Transplantation and cellular therapy.

Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease

K. Loeb, S. Heimfeld, B. Wood, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation.

M. Perales, M. Mohty, J. Wingard, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.

R. Storb, B. Storer, F. Appelbaum, 2016, Blood.

Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale.

Meei-Li W Huang, G. McDonald, P. Carpenter, 2002, Blood.

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2018, Haematologica.

Diagnosis and clinical management of chronic graft-versus-host disease

M. Flowers, Paul J. Martin, J. Sanders, 2004, International journal of hematology.

How I vaccinate blood and marrow transplant recipients.

J. Englund, P. Carpenter, 2016, Blood.

HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Non-Malignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.

T. Torgerson, R. Storb, B. Sandmaier, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.

M. Perales, A. Nagler, Z. DeFilipp, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation for AML in children.

S. Meshinchi, S. Davies, P. Carpenter, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.

M. Perales, A. Nagler, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Resilience, health, and quality of life among long‐term survivors of hematopoietic cell transplantation

Stephanie J. Lee, A. Rosenberg, K. Syrjala, 2015, Cancer.

Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors.

A. Tichelli, S. Hashmi, B. Savani, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.

M. Flowers, W. Hwang, S. Forman, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.

M. Boeckh, K. Marr, A. Upton, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

J. Wingard, J. Gea-Banacloche, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

F. M. Stewart, B. Sandmaier, F. Appelbaum, 2020, Bone Marrow Transplantation.

American Society of Transplantation and Cellular Therapy Series, 1: Enterobacterales Infection Prevention and Management after Hematopoietic Cell Transplantation.

S. Seo, S. Shelburne, S. Weissman, 2021, Transplantation and cellular therapy.

American Society for Transplantation and Cellular Therapy Series: #6 - Management of Invasive Candidiasis in Hematopoietic Cell Transplant Recipients.

G. Papanicolaou, K. Hanson, W. Steinbach, 2023, Transplantation and cellular therapy.

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

M. Bar, J. Wagner, J. Sierra, 2021, Transplantation and cellular therapy.

American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation.

G. Papanicolaou, M. Boeckh, F. Marty, 2021, Transplantation and cellular therapy.

American Society of Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation.

G. Papanicolaou, Yae-Jean Kim, R. Chemaly, 2021, Transplantation and cellular therapy.

Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia

T. Gooley, E. Nemecek, J. Sanders, 2004, Bone Marrow Transplantation.

Success of allogeneic marrow transplantation for children with severe aplastic anaemia

H. Deeg, R. Storb, B. Storer, 2012, British journal of haematology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

R. Storb, B. Storer, M. Boeckh, 2015, Haematologica.

Late Effects in Survivors After Hematopoietic Cell Transplantation in Childhood

A. Petryk, K. Baker, P. Carpenter, 2014 .

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

R. Advani, A. Nademanee, J. Friedberg, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.

M. Flowers, M. Schubert, P. Carpenter, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of children with malignancies for blood and marrow transplantation: A report from the ASTCT Committee on Practice Guidelines.

M. Kohorst, H. Stefanski, M. Qayed, 2023, Transplantation and cellular therapy.

Final adult height of patients who received hematopoietic cell transplantation in childhood.

F. Appelbaum, K. Guthrie, J. Sanders, 2005, Blood.

Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.

S. Davies, P. Mehta, M. Ayas, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Human Mesenchymal Stem Cell Therapy (Prochymal®) As A Rescue Agent For Severe Treatment Resistant GVHD In Pediatric Patients

J. Kurtzberg, V. Prasad, S. Prockop, 2010 .

Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease

J. Goldberg, B. Kurland, J. Pidala, 2014, Arthritis & rheumatology.

Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children

B. Hadland, W. Leisenring, S. Meshinchi, 2019, Bone Marrow Transplantation.

Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.

S. Massey, Stephanie J. Lee, T. Seaborn, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.

J. Kurtzberg, M. Cairo, M. Pulsipher, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

S. Davies, P. Mehta, M. Cairo, 2014, Blood.

Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome

J. Kurtzberg, M. Cairo, M. Pulsipher, 2014, Pediatric blood & cancer.

Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia.

J. Wagner, R. Krance, Chi-kong Li, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.

N. Giri, G. Marshall, P. Carpenter, 1996, Bone marrow transplantation.

Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation.

M. MacMillan, A. Alousi, M. Horwitz, 2021, Transplantation and cellular therapy.

Guidelines for Pediatric Unrelated Cord Blood Transplantation-Unique Considerations.

J. Kurtzberg, C. Martinez, J. Boelens, 2021, Transplantation and cellular therapy.

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.

Paul Martin, Lawrence Corey, H. Deeg, 2002, Blood.

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.

B. Storer, P. Westervelt, F. Appelbaum, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.

M. Mohty, Stephanie J. Lee, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of chronic graft-versus-host disease: Past, present and future

Stephanie J. Lee, M. Flowers, P. Carpenter, 2011, The Korean journal of hematology.

Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.

S. Hanash, B. Storer, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of plasma CD 163 concentration with de novo-onset chronic graft-versus-host disease

S. Hanash, Stephanie J. Lee, J. Hansen, 2017 .

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.

R. Larson, M. Perales, A. Nagler, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune deficiencies , infection , and systemic immune disorders Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation , polyendocrinopathy , enteropathy , X-linked syndrome

H. Ochs, T. Torgerson, R. Storb, 2010 .

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.

J. Wagner, R. Krance, P. Veys, 2012, Blood.

Preventing Measles among Immunosuppressed Cancer and Hematopoietic Cell Transplant Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy.

M. Kamboj, J. Englund, S. Pergam, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience

H. Deeg, R. Storb, F. Appelbaum, 2004, Bone Marrow Transplantation.

Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement.

A. Paci, M. Perales, V. Seewaldt, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease.

A. Gennery, R. Handgretinger, A. Lawitschka, 2022, Transplantation and cellular therapy.

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD

W. Wood, J. Pidala, Stephanie J. Lee, 2014, Bone Marrow Transplantation.

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-FcR-binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo.

C. Anasetti, J. Tso, O. Press, 2000, Transplantation proceedings.

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

J. Gribben, E. Montserrat, F. Awan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Li Li, Sandra A Mitchell, Kristin Baird, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical benefit of response in chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.

R. Storb, W. Leisenring, F. Appelbaum, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.

W. Wood, Stephanie J. Lee, M. Flowers, 2022, Transplantation and cellular therapy.

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

J. Pidala, Z. DeFilipp, Stephanie J. Lee, 2021, Blood advances.

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.

J. Pidala, Stephanie J. Lee, M. Flowers, 2020, Blood advances.

ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after failure of Chimeric antigen receptor T cell therapy (CAR-T) therapy.

M. Perales, Z. DeFilipp, S. Hashmi, 2022, Transplantation and cellular therapy.

Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort

C. Bollard, S. Paczesny, E. Chorvinsky, 2021, Bone Marrow Transplantation.

Validation of measurement scales in ocular graft-versus-host disease.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Ophthalmology.

Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival

J. Pidala, Stephanie J. Lee, M. Arora, 2021, Blood advances.

Assessment of ST2 for risk of death following graft-versus-host disease in the pediatric and adult age groups.

S. Hanash, R. Krance, Hao Liu, 2020, Blood.

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

K. Ness, M. Flowers, M. Arora, 2009, Bone Marrow Transplantation.

Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease

J. Pidala, Stephanie J. Lee, M. Arora, 2022, Haematologica.

W. Woods, J. Perentesis, S. Davies, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.

B. Storer, P. Carpenter, K. Baker, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation.

M. Boeckh, L. Corey, H. Kiem, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.

M. MacMillan, S. Davies, P. Mehta, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

R. Storb, B. Sandmaier, B. Storer, 2005, Bone Marrow Transplantation.

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, L. Zhao, 2016, Blood.

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant

B. Storer, M. Flowers, P. Martin, 2017, Bone Marrow Transplantation.

Vaccine Oka Varicella Meningitis in Two Adolescents

J. Englund, A. Gershon, D. Schmid, 2019, Pediatrics.

B. Kurland, M. Flowers, M. Arora, 2012 .

Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD).

B. Storer, F. Appelbaum, P. Campregher, 2009 .

Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer

G. Lyman, N. Kuderer, P. Carpenter, 2021, Cancer Investigation.

Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation.

J. Ziegler, P. Carpenter, M. Vowels, 1996, Bone marrow transplantation.

Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients.

M. Bar, Stephanie J. Lee, M. Flowers, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ASTCT Clinical practice recommendations for transplant and cellular therapies in diffuse large B-cell lymphoma.

F. Awan, M. Perales, L. Lekakis, 2023, Transplantation and cellular therapy.

Commentary: Is Immune Recovery-Based Post-Transplantation Vaccination in Children Better Than Time-Based Revaccination?

J. Englund, P. Carpenter, 2021, Transplantation and cellular therapy.

American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series.

G. Papanicolaou, M. Boeckh, R. Chemaly, 2021, Transplantation and cellular therapy.

Confounding Factors Affecting the National Institutes of Health (NIH) Chronic GVHD Organ-Specific Score and Global Severity

B. Storer, Stephanie J. Lee, M. Flowers, 2014 .

C. Kitko, J. Levine, P. Carpenter, 2011, Pediatric transplantation.

Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy.

M. Perales, Z. DeFilipp, B. Hamilton, 2023, Transplantation and cellular therapy.

Treatment of chronic graft-versus-host disease: Past, present and future

Stephanie J. Lee, M. Flowers, P. Carpenter, 2011, The Korean journal of hematology.

THE EFFECT OF IMATINIB ON CMV REACTIVATION IN HEMATOPOIETIC CELL TRANSPLANTATION

L. Corey, H. Kiem, S. Pergam, 2009 .

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

J. Wingard, K. Ballen, Y. Nieto, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2017, Blood.

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

Patient-reported treatment response in chronic graft-versus-host disease.

J. Pidala, A. Im, M. Flowers, 2023, Haematologica.

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

B. Storer, F. Appelbaum, E. Warren, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

American Society for Transplantation and Cellular Therapy Series: #5 - Management of Clostridioides difficile infection in hematopoietic cell transplant recipients.

M. Kamboj, E. Dubberke, K. Mullane, 2022, Transplantation and cellular therapy.